Possible antidiabetic and antihyperlipidaemic effect of fermented Parkia biglobosa (JACQ) extract in alloxan-induced diabetic rats

Clinical and Experimental Pharmacology and Physiology

Volumn 33, Issue 9, 2006, Pages 808-812

  Odetola, A A ^a   Akinloye, O ^b   Egunjobi, C ^a   Adekunle, W A ^a   Ayoola, A O ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b LADOKE AKINTOLA UNIVERSITY OF TECHNOLOGY   (Nigeria)

Author keywords

Diabetes; Fasting plasma glucose; Lipid profile; Parkia biglobosa

Indexed keywords

ALLOXAN; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; GLIBENCLAMIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; METHANOL; PARKIA BIGLOBOSA EXTRACT; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ALLOXAN DIABETES MELLITUS; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONDIMENT; CONTROLLED STUDY; DIET RESTRICTION; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG SCREENING; FERMENTATION; FREQUENCY ANALYSIS; GLUCOSE BLOOD LEVEL; HYPERTENSION; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MALE; MEDICAL EXAMINATION; MEDICINAL PLANT; NONHUMAN; PARKIA BIGLOBOSA; PLANT SEED; PROTEIN ANALYSIS; RAT; RISK ASSESSMENT; SPICE; STOMACH TUBE; WEIGHT GAIN; WEIGHT REDUCTION;

ANIMALS; ANTILIPEMIC AGENTS; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, EXPERIMENTAL; FABACEAE; FASTING; FERMENTATION; GLYBURIDE; HYPOGLYCEMIC AGENTS; MALE; PLANT EXTRACTS; RATS; RATS, WISTAR; SEEDS; TRIGLYCERIDES;

EID: 33747038085     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2006.04444.x     Document Type: Article

References (35)

1. Scheen JA. Drug treatment of non-insulin dependent diabetes mellitus in the 1990s. Achievements Future Dev. Drug 1997; 54: 355-68.
2. Pupim LB, Heimburger O, Qureshi AR, Ikizler TA, Stenvinkel P. Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus. Kidney Int. 2005; 68: 2368-74.
3. Sochar M, Baquer NZ, Mclean P. Glucose overutilization in diabetes: evidence from studies on the changes in hexokinase, the pentose phosphate pathway and glucuronate-xylulose pathway in rat kidney cortex in diabetes Biochem. Biophys. Res. Commun. 1979; 86: 32-9.
4. Saravanan R, Pari L. Antihyperlipidemic and antiperoxidative effect of diasulin, a polyherbal formulation in alloxan induced hyperglycemic rats. BMC Complement. Alternative Med. 2005; 5: 14-34.
5. Morel DW, Chisolm EM. Antioxidant treatment of diabetic rats inhibits oxidations and cytoxicity. J. Lipid Res. 1989; 30: 1827-34.
6. Bayness JW. Reactive oxygen in the aetiology and complications of diabetes. In: Ioanniders C, Fltt R (eds). Drug, Diet and Disease, Mechanistic Approach to Diabetes, Vol. 2. Ellis Horwood, Hertfordshire. 1995; 230-41.
7. Tiwari AK, Madhusudana Rao JM. Diabetes mellitus and multiple therapeutic approaches of phytochemicals: Present status and future prospects. Curr. Sci. 2002; 83: 30-8.
8. Bhattaram VA, Cercefe M, Cohlest C, Vest M, Deundo FH. Pharmacokinetics bioavailability herbal medicinal products. Phytomedicine 2002; 9: 1-36.
9. Bailey CJ, Day C. Traditional treatments for diabetes. Diabetes Care 1989; 12: 553-64.
10. WHO Expert Committee on Diabetes Mellitus. Second Report. Technical Report Series 646. World Health Organisation, Geneva. 1980.
11. Ajaiyeoba EO. Phytochemical and antibacterial properties of Parkia biglobosa and Parkia biolor leaf extract. Aghil J. Biomed. Res. 2000; 5: 125-9.
12. Assane M, Baba Moussa R, Bassene E, Sere A. Antihypertensive action of Parkia biglobosa (Jacq) Benth seeds in rats. Darkar Med. 1993; 38: 49-54.
13. Agunu A, Yusuf S, Andrew GO, Zezi A, Abdurahman EM. Evaluation of fine medicinal plants used in diarrhoea treatment in Nigeria. J. Ethnopharmacol. 2005; 101: 1-7.
14. Fetuga BL, Babatunde GM, Oyenuga VA. Protein quality of some unusual protein foods: African locust bean seed. Br. J. Nutr. 1974; 3: 1-6.
15. Loew S, Kaszkin M. Approaching the problem of bioequivalence of herbal medicinal products. Phytother. Res. 2002; 16: 705-11.
16. Kouadia F, Kanko C, Juge M et al. Analgesic and anti-inflammatory activities of an extract from Parkia biglobosa used in traditional medicine in the Ivory Coast. Phytother. Res. 2000; 14: 635-7.
17. Bamak BR, Gold AH. Effect of alloxan diabetes on the turnover of rat liver glycogen synthose. Comparisons with liver phophory lase. J. Biol. Chem. 1982; 257: 8775-80.
18. Nerurkar MA, Satav JG, Katyare SS. Insulin-dependent changes in lysosomal cathepsin D activity in rat liver, kidney, brain and heart. Diabetologia 1998; 31: 119-22.
19. Trinder RP. Determination of blood glucose using 4-aminophenazone as oxygen acceptor. J. Clin. Pathol. 1960; 22: 246-50.
20. Friedwald WT, Levy RI, Fredicksm D. Estimation of low-density lipoprotein cholesterol without the use of the preparative ultracentrifuge. Clin. Chem. 1972; 18: 499-502.
21. Bierman EL, Ameral JAP, Balknap BH. Hyperlipidemia and diabetes mellitus. Diabetes 1975; 25: 509-15.
22. Jackson JE, Bressler R. Clinical pharmacology of sulphonylurea as hypoglycemic agent: Part I. Drugs 1981; 22: 211-45.
23. Prince P, Stanely M, Menon PV, Pari L. Hypoglycaemic activity of Syzigium cumini seeds: Effect on lipid peroxidation in alloxan diabetic rats. J. Enthopharmacol. 1998; 61: 1-7.
24. Venkateswaran S, Pari L, Saravenan G. Effect of Phaseolus vulgaris on circulatory antioxidants and lipids in streptozotocin-induced diabetic rats. J. Med. Food 2002; 5: 97-104.
25. Latha M, Pari L. Preventive effects of Cassia auriculata L. flowers on brain lipid peroxidation in rats treated with streptozotocin. Mol. Cell. Biochem. 2003; 243: 23-8.
26. Latha M, Pari L. Antihyperglycaemic effect of Cassia auriculata in experimental diabetes and its effects in key metabolic enzymes involved in carbohydrate metabolism. Clin. Exp. Pharmacol. Physiol. 2003; 30: 38-43.
27. Akinmoladun CA, Akinloye O. Effect of Aloe barbedensis on the lipid profile and fasting blood sugar concentration of rabbits fed high cholesterol diet. Global J. Pure Appl. Sci. 2004; 1: 139-42.
28. Loci AS, Shaabha M, Khazraji AL, Husain A, Twaija A. Hypoglycemic effect of a valuable extract on some blood parameters in diabetic animals. J. Ethnopharmacol. 1994; 43: 167-171.
29. Ahardh CD, Bjorgell P, Nilson EP. The effect of tolnetamide in lipoproteins and lipoprotein lipase and hormone sensitive lipase. Diabetes Res. Clin. Pract. 1999; 46: 99-108.
30. Frayn KN. Insulin resistance and lipid metabolism. Curr. Opin. Lipidol. 1993; 4: 197-204.
31. Brecher P, Chobanian AV, Small DM, Van Sidde W, Tgercyak A, Baler J. Relationship of an abnormal plasma lipoprotein to protect from atherosclerosis in the cholesterol fed diabetic rabbit. J. Clin. Invest. 1983; 5: 1553-62.
32. Bopanna KN, Kannan J, Suchma G, Balaraman R, Ranthod SP. Antidiabetic and antihyperlipidemic effect of neem seed, kernal powder on alloxan diabetic rabbits. Ind. J. Pharmacol. 1997; 29: 162-7.
33. Dairo G, Antonio C, Gluseppe P. Oxidative stress and diabetes complications. Diabetes Care 1996; 19: 257-67.
34. Agbedana EO. Cholesterol and Your health. Inaugural Lecture Delivered at the University of Ibadan, 1999. John Archers Publication, Ibadan.
35. Castelli L. Epidemiology of coronary heart disease. Am. J. Med. 1984; 76: 4-12.